Company Filing History:
Years Active: 1999-2014
Title: Innovations of Hongjiang Wu
Introduction
Hongjiang Wu is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of biotechnology, particularly in the optimization of RNA cleavage. With a total of 7 patents, his work has advanced the understanding and application of oligonucleotides in therapeutic contexts.
Latest Patents
One of his latest patents is titled "Compositions and methods for optimizing cleavage of RNA by RNase H." This invention provides compositions and methods aimed at enhancing the cleavage of RNA species by RNase H. The invention includes oligonucleotides that feature two or more regions of differing conformation, with a transitional nucleobase that modulates the transfer of helical conformation between regions. Another notable patent is the "Nuclease-based method for detecting and quantitating oligonucleotides." This method allows for the quantitation of oligonucleotides in bodily fluids and extracts, facilitating the detection and localization of oligonucleotides for therapeutic and pharmacokinetic purposes.
Career Highlights
Throughout his career, Hongjiang Wu has worked with leading companies in the biotechnology sector, including Isis Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. His innovative approaches have positioned him as a key figure in the development of RNA-based therapies.
Collaborations
He has collaborated with notable professionals in the field, including Stanley T. Crooke and Walter F. Lima. These collaborations have further enriched his research and contributions to biotechnology.
Conclusion
Hongjiang Wu's work exemplifies the intersection of innovation and biotechnology. His patents and collaborations have significantly impacted the field, paving the way for advancements in RNA research and therapeutic applications.